ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 21 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $23,000 | -34.3% | 9,044 | -9.6% | 0.00% | – |
| Q2 2020 | $35,000 | -31.4% | 10,000 | 0.0% | 0.00% | – |
| Q1 2020 | $51,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
| Q4 2019 | $51,000 | -19.0% | 10,000 | -50.0% | 0.00% | – |
| Q3 2019 | $63,000 | -11.3% | 20,000 | 0.0% | 0.00% | – |
| Q2 2019 | $71,000 | -1.4% | 20,000 | 0.0% | 0.00% | – |
| Q1 2019 | $72,000 | +20.0% | 20,000 | 0.0% | 0.00% | – |
| Q4 2018 | $60,000 | -38.1% | 20,000 | 0.0% | 0.00% | – |
| Q3 2018 | $97,000 | -34.9% | 20,000 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $149,000 | -17.2% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $180,000 | 0.0% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $180,000 | -9.1% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $198,000 | +7.6% | 20,000 | -33.3% | 0.00% | 0.0% |
| Q2 2017 | $184,000 | 0.0% | 30,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $184,000 | +1126.7% | 30,000 | +2900.0% | 0.00% | – |
| Q4 2013 | $15,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acrospire Investment Management LLC | 8,355 | $61,000 | 0.04% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 70,000 | $508,000 | 0.01% |
| Financial Architects, Inc | 2,000 | $15,000 | 0.00% |
| FineMark National Bank & Trust | 3,473 | $25,000 | 0.00% |
| JFS WEALTH ADVISORS, LLC | 1,000 | $7,000 | 0.00% |
| Penserra Capital Management LLC | 2,540 | $18,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,284 | $10,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,673 | $19,000 | 0.00% |
| Plante Moran Financial Advisors, LLC | 300 | $2,000 | 0.00% |
| Cutler Group LLC / CA | 2,404 | $17,000 | 0.00% |